{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T22:22:16Z","timestamp":1783981336398,"version":"3.55.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T00:00:00Z","timestamp":1537747200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Radiol"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s11604-018-0780-x","type":"journal-article","created":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T11:18:13Z","timestamp":1537787893000},"page":"686-690","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Standardization of [F-18]FDG PET\/CT for response evaluation by the Radiologic Society of North America-Quantitative Imaging Biomarker Alliance (RSNA-QIBA) profile: preliminary results from the Japan-QIBA (J-QIBA) activities for Asian international multicenter phase II trial"],"prefix":"10.1007","volume":"36","author":[{"given":"Hyeyeol","family":"Bae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehito","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuko","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Sonehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiko","family":"Nagahama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ukihide","family":"Tateishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,24]]},"reference":[{"key":"780_CR1","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, editors. WHO classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised. 4th ed. Lyon: International Agency for Research on Cancer; 2017."},{"key":"780_CR2","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1093\/annonc\/mdh409","volume":"15","author":"JO Armitage","year":"2004","unstructured":"Armitage JO, Vose JM, Weisenburger DD. Towards understanding the peripheral T-cell lymphomas. Ann Oncol. 2004;15:1447\u20139.","journal-title":"Ann Oncol."},{"key":"780_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/hon.836","volume":"26","author":"D Rodriguez-Abreu","year":"2008","unstructured":"Rodriguez-Abreu D, Filho VB, Zucca E. Peripheral T-cell lymphomas, unspecified (or not otherwise specified): a review. Hematol Oncol. 2008;26:8\u201320.","journal-title":"Hematol Oncol."},{"key":"780_CR4","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/bjh.14477","volume":"176","author":"D Chihara","year":"2017","unstructured":"Chihara D, Fanale MA, Miranda RN, Noorani M, Westin JR, Nastoupil LJ, et al. The survival outcome of patients with relapsed\/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma. Br J Haematol. 2017;176:750\u20138.","journal-title":"Br J Haematol."},{"key":"780_CR5","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32:3059\u201368.","journal-title":"J Clin Oncol."},{"key":"780_CR6","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ejca.2008.10.030","volume":"45","author":"DJ Sargent","year":"2009","unstructured":"Sargent DJ, Rubinstein L, Schwartz L, Dancey JE, Gatsonis C, Dodd LE, et al. Validation of novel imaging methodologies for use as cancer clinical trial end-points. Eur J Cancer. 2009;45:290\u20139.","journal-title":"Eur J Cancer."},{"key":"780_CR7","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1593\/tlo.09208","volume":"2","author":"CR Meyer","year":"2009","unstructured":"Meyer CR, Armato SG, Fenimore CP, McLennan G, Bidaut LM, Barboriak DP, et al. Quantitative imaging to assess tumor response to therapy: common themes of measurement, truth data, and error sources. Transl Oncol. 2009;2:198\u2013210.","journal-title":"Transl Oncol."},{"key":"780_CR8","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1148\/radiol.10100799","volume":"258","author":"AJ Buckler","year":"2011","unstructured":"Buckler AJ, Bresolin L, Dunnick NR, Sullivan DC. A collaborative enterprise for multi-stakeholder participation in the advancement of quantitative imaging. Radiology. 2011;258:906\u201314.","journal-title":"Radiology"},{"key":"780_CR9","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1148\/radiol.10100800","volume":"259","author":"AJ Buckler","year":"2011","unstructured":"Buckler AJ, Bresolin L, Dunnick NR, Sullivan DC, Aerts HJ, Bendriem B, et al. Quantitative imaging test approval and biomarker qualification: interrelated but distinct activities. Radiology. 2011;259:875\u201384.","journal-title":"Radiology"},{"key":"780_CR10","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1148\/radiol.2015142202","volume":"277","author":"DC Sullivan","year":"2015","unstructured":"Sullivan DC, Obuchowski NA, Kessler LG, Raunig DL, Gatsonis C, Huang EP, et al. Metrology standards for quantitative imaging biomarkers. Radiology. 2015;277:813\u201325.","journal-title":"Radiology"},{"key":"780_CR11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nrclinonc.2016.162","volume":"14","author":"JP O'Connor","year":"2017","unstructured":"O'Connor JP, Aboagye EO, Adams JE, Aerts HJ, Barrington SF, Beer AJ, et al. Imaging biomarker roadmap for cancer studies. Nat Rev Clin Oncol. 2017;14:169\u201386.","journal-title":"Nat Rev Clin Oncol."},{"key":"780_CR12","unstructured":"Quantitative Imaging Biomarkers Alliance. Radiological Society of North America. \n                    https:\/\/www.rsna.org\/QIBA\/"},{"key":"780_CR13","unstructured":"FDG-PET, CT,. Technical Committee. FDG-PET, CT,. as an Imaging Biomarker Measuring Response to Cancer Therapy, Quantitative Imaging Biomarkers Alliance, Version 1.11, Publicly Reviewed Version. QIBA, November 10, 2016. Available from: \n                    https:\/\/www.rsna.org\/QIBA\/"},{"key":"780_CR14","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s12149-014-0849-2","volume":"28","author":"H Fukukita","year":"2014","unstructured":"Fukukita H, Suzuki K, Matsumoto K, Terauchi T, Daisaki H, Ikari Y, et al. Japanese guideline for the oncology FDG-PET\/CT data acquisition protocol: synopsis of Version 2.0. Ann Nucl Med. 2014;28:693\u2013705.","journal-title":"Ann Nucl Med."},{"key":"780_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.tox.2006.07.009","volume":"227","author":"S Hirano","year":"2006","unstructured":"Hirano S, Kobayashi Y. Cytotoxic effects of S-(dimethylarsino)-glutathione: a putative intermediate metabolite of inorganic arsenicals. Toxicology. 2006;227:45\u201352.","journal-title":"Toxicology"},{"key":"780_CR16","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1158\/1535-7163.MCT-08-1072","volume":"8","author":"SM Matulis","year":"2009","unstructured":"Matulis SM, Morales AA, Yehiayan L, Croutch C, Gutman D, Cai Y, et al. Darinaparsin induces a unique cellular response and is active in an arsenic trioxide-resistant myeloma cell line. Mol Cancer Ther. 2009;8:1197\u2013206.","journal-title":"Mol Cancer Ther."},{"key":"780_CR17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/ajh.22232","volume":"87","author":"PJ Hosein","year":"2012","unstructured":"Hosein PJ, Craig MD, Tallman MS, Boccia RV, Hamilton BL, Lewis JJ, et al. A multicenter phase II study of darinaparsin in relapsed or refractory Hodgkin's and non-Hodgkin's lymphoma. Am J Hematol. 2012;87:111\u20134.","journal-title":"Am J Hematol."},{"key":"780_CR18","doi-asserted-by":"publisher","first-page":"6023","DOI":"10.1158\/1078-0432.CCR-14-1532","volume":"20","author":"D Ravi","year":"2014","unstructured":"Ravi D, Bhalla S, Gartenhaus RB, Crombie J, Kandela I, Sharma J, et al. The novel organic arsenical darinaparsin induces MAPK-mediated and SHP1-dependent cell death in T-cell lymphoma and Hodgkin lymphoma cells and human xenograft models. Clin Cancer Res. 2014;20:6023\u201333.","journal-title":"Clin Cancer Res."},{"key":"780_CR19","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s12149-014-0815-z","volume":"28","author":"YS Lee","year":"2014","unstructured":"Lee YS, Kim JS, Kim KM, Kang JH, Lim SM, Kim HJ. Performance measurement of PSF modeling reconstruction (True X) on Siemens Biograph TruePoint TrueV PET\/CT. Ann Nucl Med. 2014;28:340\u20138.","journal-title":"Ann Nucl Med."},{"issue":"Suppl 1","key":"780_CR20","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00259-017-3727-z","volume":"44","author":"CS Vos van der","year":"2017","unstructured":"van der Vos CS, Koopman D, Rijnsdorp S, Arends AJ, Boellaard R, van Dalen JA, et al. Quantification, improvement, and harmonization of small lesion detection with state-of-the-art PET. Eur J Nucl Med Mol Imaging. 2017;44(Suppl 1):4\u201316.","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"780_CR21","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s12149-012-0676-2","volume":"27","author":"H Daisaki","year":"2013","unstructured":"Daisaki H, Tateishi U, Terauchi T, Tatsumi M, Suzuki K, Shimada N, et al. Standardization of image quality across multiple centers by optimization of acquisition and reconstruction parameters with interim FDG-PET\/CT for evaluating diffuse large B cell lymphoma. Ann Nucl Med. 2013;27:225\u201332.","journal-title":"Ann Nucl Med."}],"container-title":["Japanese Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11604-018-0780-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-018-0780-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-018-0780-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T23:16:50Z","timestamp":1569280610000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11604-018-0780-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,24]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["780"],"URL":"https:\/\/doi.org\/10.1007\/s11604-018-0780-x","relation":{},"ISSN":["1867-1071","1867-108X"],"issn-type":[{"value":"1867-1071","type":"print"},{"value":"1867-108X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,24]]},"assertion":[{"value":"27 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}